Cite
HARVARD Citation
Shen, Y. et al. (2021). The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Hepatology communications. 5 (9), pp. 1622-1623. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shen, Y. et al. (2021). The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Hepatology communications. 5 (9), pp. 1622-1623. [Online].